Dr. Pflederer is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
420 NE Glen Oak Ave
Ste 401
Peoria, IL 61603Phone+1 309-676-8123Fax+1 309-676-8455
Education & Training
- University of Iowa Hospitals and ClinicsFellowship, Nephrology, 1991 - 1993
- University of Iowa Hospitals and ClinicsResidency, Internal Medicine, 1988 - 1991
- University of Illinois College of MedicineClass of 1988
Certifications & Licensure
- IL State Medical License 1992 - 2026
- NY State Medical License 2024 - 2026
- TN State Medical License 2024 - 2026
- TX State Medical License 2024 - 2026
- CO State Medical License 2024 - 2025
- IN State Medical License 2024 - 2025
- MD State Medical License 2024 - 2025
- American Board of Internal Medicine Nephrology
- Join now to see all
Awards, Honors, & Recognition
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2011
Clinical Trials
- Study Comparing Lutonix AV Drug Coated Balloon vs Standard Balloon for Treatment of Dysfunctional AV Fistulae Start of enrollment: 2015 Jun 01
Publications & Presentations
PubMed
- 57 citationsProspective, Randomized, Concurrently-Controlled Study of a Stent Graft versus Balloon Angioplasty for Treatment of Arteriovenous Access Graft Stenosis: 2-Year Results...Ziv J Haskal, Theodore F. Saad, Jeffery G. Hoggard, Randy I. Cooper, George S. Lipkowitz
Journal of Vascular and Interventional Radiology. 2016-08-01 - 97 citationsMedicare Costs Associated With Arteriovenous Fistulas Among US Hemodialysis PatientsMae Thamer, Timmy Lee, Haimanot Wasse, Marc H. Glickman, Joyce Qian
American Journal of Kidney Diseases. 2018-07-01 - 2 citationsIN.PACT AV Access Trial: Economic Evaluation of Drug-Coated Balloon Treatment for Dysfunctional Arteriovenous Fistulae Based on 12-Month Clinical Outcomes.Jan B Pietzsch, Benjamin P Geisler, Bharati Manda, Sanjay Misra, Sean P Lyden
Journal of Vascular and Interventional Radiology. 2022-08-01
Press Mentions
- Proteon Therapeutics Announces Two Presentations at the American Society of Diagnostic and Interventional Nephrology MeetingFebruary 6th, 2017
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: